<DOC>
	<DOCNO>NCT01281033</DOCNO>
	<brief_summary>To compare rheolytic thrombectomy ( RT ) manual thrombus aspiration ( MTA ) patient acute ST-segment elevation myocardial infarction ( STEMI ) undergo primary PCI . Occlusive thrombosis trigger disrupt eroded atherosclerotic plaque anatomic substrate ST-segment elevation myocardial infarction ( STEMI ) . Due substrate , macro- microembolization percutaneous coronary intervention ( PCI ) AMI frequent may result obstruction microvessel network , decrease efficacy reperfusion myocardial salvage . Direct stenting without predilation postdilation simplistic approach problem embolization , may decrease embolization incidence no-reflow phenomenon . Other approach problem microvessel embolization include thrombectomy stent implantation , use antiembolic device ( filter occlusive device retrieval thromboembolic material stent implantation ) . Most concluded study remove thrombus stenting use manual aspiration catheter meta-analyses derive study support use manual thrombus aspiration ( MTA ) catheter set primary PCI . MTA currently recommend set primary PCI Class II b recommendation ; level evidence B. Rheolytic thrombectomy ( RT ) use multiple jet saline solution aspiration base Bernoulli effect proven effective decrease major adverse event PCI saphenous vein graft native coronary artery angiographic evidence thrombus , 2 3 conclude study show good reperfusion clinical outcome patient randomize RT compare control .</brief_summary>
	<brief_title>CompariSon Manual Aspiration With Rheolytic Thrombectomy Patients Undergoing Primary PCI . The SMART-PCI Trial</brief_title>
	<detailed_description>The SMART Study on-label , randomize , 2-arms , prospective study patient STEMI undergo primary PCI . Diagnosis STEMI base ECG evidence ischemic ST change , clinical symptom , elevate CK CK-MB cardiac enzyme . Patients eligible Study provide write informed consent include study . Inclusion Criteria : - Patient &gt; 18 year age . - Patient ST-segment elevation least 0.1 mV 2 contiguous lead presumably new LBBB type infarct . - Patient 's AMI presentation great 30 minute less 6 hour symptom onset . - Patient provide write informed consent . - Patient childbearing potential pregnant . - Target artery reference vessel diameter least 2.5 mm visual assessment baseline angiography . Exclusion Criteria : - Known prior history renal insufficiency ( serum creatinine 2.0 mg/dL ) . - Cardiogenic shock . - Prior administration thrombolysis current infarction . - Participation another study . - Major surgery within past 6 week . - History stroke within 30 day , history hemorrhagic stroke . - Severe hypertension ( systolic BP &gt; 200 mm Hg diastolic BP &gt; 110 mm Hg ) control antihypertensive therapy . - Known neutropenia ( &lt; 1000 neutrophil per mm3 ) know severe thrombocytopenia ( &lt; 50,000 platelet per mm3 ) . - Patient unwilling receive blood product . - Previously stented IRA ( stent thrombosis ) . - Inability identify IRA . - Severe vessel tortuosity enable OCT assessment .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<criteria>Clinical inclusion criterion : Patient &gt; 18 year age . Patient STsegment elevation least 0.1 mV 2 contiguous lead presumably new LBBB type infarct . Patient 's AMI presentation great 30 minute less 6 hour symptom onset . Patient provide write informed consent . Patient childbearing potential pregnant Angiographic inclusion criterion : All patient without evidence thrombus eligible . Target artery reference vessel diameter 2.5 mm visual assessment baseline angiography . Clinical exclusion criterion : Known prior history renal insufficiency ( serum creatinine 2.0 mg/dL ) . Cardiogenic shock . Prior administration thrombolysis current infarction . Participation another study . Major surgery within past 6 week . History stroke within 30 day , history hemorrhagic stroke . Severe hypertension ( systolic BP &gt; 200 mm Hg diastolic BP &gt; 110 mm Hg ) control antihypertensive therapy . Known neutropenia ( &lt; 1000 neutrophil per mm3 ) know severe thrombocytopenia ( &lt; 50,000 platelet per mm3 ) . Patient unwilling receive blood product Angiographic exclusion criterion : Previously stented IRA ( stent thrombosis ) . Inability identify IRA . Severe vessel tortuosity enable OCT assessment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>primary PCI</keyword>
	<keyword>ST-segment elevation myocardial infarction</keyword>
	<keyword>thrombus aspiration</keyword>
</DOC>